Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Last 25 million dollar dilution

View:

Post by Beanie28 on Feb 17, 2021 7:53pm

Last 25 million dollar dilution

what happened to the 28 million they just raised In June? Am I missing something?

190

Comment

Comment by Alex1967 on Feb 17, 2021 9:53pm

They have $16 million in cash and cash equivalent. Keep in mind they had to do a lot of animal testing on (absorption, metabolism, and excretion) before they can apply for IND for phase 3. The extra cash allows them to negotiate with potential partners from point of strength.

166

Comment

Comment by RalphRalph on Feb 17, 2021 10:03pm

The fact that they had to offer warrants is not a good sign. When demand is very high, no warrants are needed to sweeten the deal. The terms of the warrants are also unfavorable - $7.50 / 3 years / no acceleration clause. The constant need for warrants in their raises reflects the cost of management's inability to get the company onto the NASDAQ. From a ...more

218

Comment